Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
795
archived clinical trials in
Endometriosis

Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Clinical Physiology Associates
mi
from
Fort Myers, FL
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Clinical Physiology Associates
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Solutions Through Advanced Research Inc.
mi
from
Jacksonville, FL
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Solutions Through Advanced Research Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Florida Research Center Inc.
mi
from
Miami, FL
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Florida Research Center Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
A Premier Medical Research of Florida, LLC
mi
from
Orange City, FL
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
A Premier Medical Research of Florida, LLC
mi
from
Orange City, FL
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Omega Research Orlando
mi
from
Orlando, FL
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Omega Research Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Oviedo Medical Research, LLC
mi
from
Oviedo, FL
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Oviedo Medical Research, LLC
mi
from
Oviedo, FL
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Augusta University Medical Center
mi
from
Augusta, GA
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Augusta University Medical Center
mi
from
Augusta, GA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
IACT Health
mi
from
Columbus, GA
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
IACT Health
mi
from
Columbus, GA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Advanced Gynecologic Surgical Institute
mi
from
Park Ridge, IL
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Advanced Gynecologic Surgical Institute
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
GTC Research
mi
from
Shawnee Mission, KA
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
GTC Research
mi
from
Shawnee Mission, KA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Southern Clinical Research Associates
mi
from
Metairie, LA
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Southern Clinical Research Associates
mi
from
Metairie, LA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Omni Fertility and Laser Institute
mi
from
Shreveport, LA
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Omni Fertility and Laser Institute
mi
from
Shreveport, LA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
NECCR Primacare Research, LLC
mi
from
Fall River, MA
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
NECCR Primacare Research, LLC
mi
from
Fall River, MA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Great Lakes Research Group, Inc.
mi
from
Saginaw, MI
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Great Lakes Research Group, Inc.
mi
from
Saginaw, MI
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Robert Wood Johnson University Hospital
mi
from
New Brunswick, NJ
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Robert Wood Johnson University Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Bosque Women's Care
mi
from
Albuquerque, NM
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Bosque Women's Care
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Women's Center for Pelvic Health
mi
from
Charlotte, NC
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Women's Center for Pelvic Health
mi
from
Charlotte, NC
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Carolina Women's Research and Wellness Center
mi
from
Durham, NC
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Carolina Women's Research and Wellness Center
mi
from
Durham, NC
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Unified Women's Clinical Research
mi
from
Greensboro, NC
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Unified Women's Clinical Research
mi
from
Greensboro, NC
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Unified Women's Clinical Research - Morehead City
mi
from
Morehead City, NC
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Unified Women's Clinical Research - Morehead City
mi
from
Morehead City, NC
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Unified Women's Clinical Research
mi
from
Raleigh, NC
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Unified Women's Clinical Research
mi
from
Raleigh, NC
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Wake Research Asssociates
mi
from
Raleigh, NC
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Wake Research Asssociates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Unified Women's Clinical Research
mi
from
Winston-Salem, NC
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Unified Women's Clinical Research
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Seven Hills Women's Health Centers
mi
from
Cincinnati, OH
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Seven Hills Women's Health Centers
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Columbus OB-GYN/Radiant Research
mi
from
Columbus, OH
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Columbus OB-GYN/Radiant Research
mi
from
Columbus, OH
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of South Carolina
mi
from
Charleston, SC
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Fusion Clinical Research of Spartanburg
mi
from
Spartanburg, SC
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Fusion Clinical Research of Spartanburg
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
VitaLink Research-Spartanburg
mi
from
Spartanburg, SC
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
VitaLink Research-Spartanburg
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Signature GYN Services, Pllc
mi
from
Fort Worth, TX
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Signature GYN Services, Pllc
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Willowbend Health and Wellness Associates
mi
from
Frisco, TX
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Willowbend Health and Wellness Associates
mi
from
Frisco, TX
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Network
mi
from
Houston, TX
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Network
mi
from
Houston, TX
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Woman's Hospital of Texas
mi
from
Houston, TX
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Woman's Hospital of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Centex Studies Inc
mi
from
Houston, TX
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Centex Studies Inc
mi
from
Houston, TX
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Diagnostic Clinic of Longview, PA
mi
from
Longview, TX
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Diagnostic Clinic of Longview, PA
mi
from
Longview, TX
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Advanced Clinical Research
mi
from
Salt Lake City, UT
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Advanced Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Aventiv Research
mi
from
Columbus, OH
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Aventiv Research
mi
from
Columbus, OH
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Precision Trials
mi
from
Phoenix, AZ
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Precision Trials
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Compass Research LLC
mi
from
Orlando, FL
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Health
mi
from
Clemmons, NC
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Health
mi
from
Clemmons, NC
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Tidewater Clinical Research
mi
from
Norfolk, VA
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Tidewater Clinical Research
mi
from
Norfolk, VA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Kepler Universitätsklinikum
mi
from
Linz,
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Kepler Universitätsklinikum
mi
from
Linz,
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Olympia Clinical Trials
mi
from
Los Angeles, CA
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Olympia Clinical Trials
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Invictus Clinical Research Group, LLC
mi
from
Miami, FL
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Invictus Clinical Research Group, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
West Coast OB/GYN Associates
mi
from
San Diego, CA
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
West Coast OB/GYN Associates
mi
from
San Diego, CA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
California Center for Clinical Research
mi
from
Arcadia, CA
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
California Center for Clinical Research
mi
from
Arcadia, CA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
Atlanta Gynecology Research Institute
mi
from
Peachtree Corners, GA
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
Atlanta Gynecology Research Institute
mi
from
Peachtree Corners, GA
Click here to add this to my saved trials
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated:  12/31/1969
ClinSearch, LLC
mi
from
Chattanooga, TN
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Status: Enrolling
Updated: 12/31/1969
ClinSearch, LLC
mi
from
Chattanooga, TN
Click here to add this to my saved trials